1 recruiting, 1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Perivascular Epithelioid Cell Tumor, Malignant: new trials by email Literature Review of Perivascular Epithelioid Cell Tumor, Malignant trials Research Report on Perivascular Epithelioid Cell Tumor, Malignant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ivonescimab in the Treatment of Multiple Advanced Tumors Ivocizumab - Pheochromocytoma/Paraganglioma, Rhabdomyosarcoma | Phase 2 | Recruiting | Fudan University | 400 | 2024-11-20 | 2025-08-24 |
| Molecular Characterization of Perivascular Epithelioid Cell Tumors Perivascular Epithelioid Cell Tumor, Malignant | Unknown | University Hospital, Strasbourg, France | 100 | 2019-12-01 | 2022-11-15 |
Angiomyolipoma (2) · Perivascular Epithelioid Cell Neoplasms (2) · Carcinoma (1) · Carcinoma, Basal Cell (1) · Carcinoma, Neuroendocrine (1) · Carcinoma, Transitional Cell (1) · Kidney Neoplasms (1) · Lymphangioleiomyomatosis (1) · Paget Disease, Extramammary (1) · Paraganglioma (1) · Penile Neoplasms (1) · Pheochromocytoma (1) · Prostatic Neoplasms (1) · Rhabdomyosarcoma (1) · Sarcoma (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Adipose Tissue (2) · Neoplasms, Connective and Soft Tissue (2) · Adenocarcinoma (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Kidney Diseases (1) · Lymphangiomyoma (1)
Fudan University (1) · University Hospital, Strasbourg, France (1)
China (1) · France (1)